prospective observational study to assess efficacy and safety of nivolumab in patients with recurrent non-small cell lung cancer
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000023210
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)inadequate patients to administrate nivolmab 2)patients that the investigators identify inadequate for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate and their clinical profiling
- Secondary Outcome Measures
Name Time Method